COMMUNIQUÉS West-GlobeNewswire

Biomerica adds Harry Leider, MD, MBA to Strategic Advisory Board
19/04/2018
IRVINE, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ) today announced that it has added Harry L. Leider, MD, MBA to its Strategic Advisor Board, which is chaired by Edward W. (Ned) Barnholt [...]
Sharps Compliance Announces Third Quarter Fiscal 2018 Conference Call and Webcast
19/04/2018
HOUSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED ) announced today that it will release its third quarter results for the period ended March 31, 2018, before the opening of the financial [...]
Metabolon to Provide Metabolomic Profiling for the U.S. Veterans Administration Million Veteran Program
19/04/2018
RESEARCH TRIANGLE PARK, N.C. and ATLANTA, Ga., April 19, 2018 (GLOBE NEWSWIRE) -- Metabolon, Inc. , the global leader in metabolomics, announced today that the U.S. Department of Veterans Affairs (VA) has been [...]
Matinas BioPharma to Present Positive Preclinical Data of MAT2203 at the 28th European Congress of Clinical Microbiology and Infectious Disease
19/04/2018
BEDMINSTER, N.J., April 19, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications [...]
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse® in MuSK Antibody Positive Myasthenia Gravis
19/04/2018
Pivotal Study sites in U.S. and Italy CORAL GABLES, Fla., April 19, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and [...]
iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37
19/04/2018
Company to showcase advanced, multi-platform electronic brachytherapy (eBx) technology in booth 6800 NASHUA, N.H. and BARCELONA, Spain, April 19, 2018 (GLOBE NEWSWIRE) -- ESTRO Booth 6800 -- iCAD, Inc. (NASDAQ: ICAD ), [...]
AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology
19/04/2018
Includes Initial Data from SMA Type 1 Pivotal Trial (STR1VE) and 24-Month Follow-Up Data from Phase 1 Trial CHICAGO, April 19, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company [...]
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
19/04/2018
KB103 represents the first investigational HSV-1 based gene therapy for the severe skin disorder dystrophic epidermolysis bullosa to receive this designation KB103 previously received Orphan Drug Designation for DEB [...]
Taconic Biosciences Launches New Inflammatory Bowel Disease Models
19/04/2018
RENSSELAER, N.Y., April 19, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, announces the launch of several new inflammatory bowel [...]
Golden Leaf Holdings to Hold Conference Call to Review Fiscal Year 2017 Results
19/04/2018
TORONTO, April 19, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that it [...]
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine
19/04/2018
More than 1,600 subjects enrolled in PROTECT study Topline data expected mid-2019 CAMBRIDGE, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV ) (“VBI”) today announced the completion of [...]
Albireo to Present Data from Two Studies on Cholestatic Liver Disease at the 51st ESPGHAN Annual Meeting
19/04/2018
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today that findings from two [...]
Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives
19/04/2018
- Company to terminate the ADAPT study – - Company has retained Stifel to provide advice on possible strategic alternatives – - Trading in the common stock to be transferred from Nasdaq to the OTCQB Venture Market - [...]
DLT Resolution Acquires Operating Assets of Canadian Telecom Service Provider
19/04/2018
Las Vegas, NV, April 19, 2018 (GLOBE NEWSWIRE) -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) and Information Technology company that services the healthcare and telecommunications [...]
Athenex, Inc. Receives U.S. FDA Orphan Drug Designation for Oraxol for the Treatment of Angiosarcoma
19/04/2018
BUFFALO, N.Y., April 19, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
ICC Labs Enters Into Letter of Intent With Eurofarma Uruguay S.A., a Member of the Brazilian-Owned Multinational Eurofarma Group of Pharmaceutical Companies
19/04/2018
VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V: ICC ) (Frankfurt: 2Q9 ) is pleased to announce that one of its Uruguayan subsidiaries has entered into [...]
Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical Trial
19/04/2018
Summit Therapeutics plc ("Summit" or the "Company") Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical Trial Top-line Data On Track to be Reported During Q3 2018 Oxford, UK, and Cambridge, MA, US, 19 April [...]
Tetraphase Pharmaceuticals to Present Data at the 38th Annual Meeting of the Surgical Infection Society
19/04/2018
WATERTOWN, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
EyePoint Pharmaceuticals Announces Third Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
19/04/2018
Conference Call Scheduled for 4:30 p.m. ET on Tuesday, May 8th WATERTOWN, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT ) (ASX:PVA), a specialty biopharmaceutical company [...]

Pages